Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial.
Fernández-Mateos J, Pérez-García J, Seijas-Tamayo R, Mesía R, Rubió-Casadevall J, García-Girón C, Iglesias L, Carral Maseda A, Adansa Klain JC, Taberna M, Vazquez S, Gómez MA, Del Barco E, Ocana A, González-Sarmiento R, Cruz-Hernández JJ. Fernández-Mateos J, et al. Sci Rep. 2020 Oct 6;10(1):16634. doi: 10.1038/s41598-020-72927-2. Sci Rep. 2020. PMID: 33024167 Free PMC article.
Analysis of bcl-2 in sporadic breast carcinoma.
Dueñas-González A, Abad-Hernández MM, Cruz-Hernández JJ, González-Sarmiento R. Dueñas-González A, et al. Cancer. 1997 Dec 1;80(11):2100-8. doi: 10.1002/(sici)1097-0142(19971201)80:11<2100::aid-cncr9>3.0.co;2-#. Cancer. 1997. PMID: 9392332
SEOM clinical guidelines for the treatment of head and neck cancer.
Mesía Nin R, Pastor Borgoñón M, Cruz Hernández JJ, Isla Casado D; SEOM (Spanish Society for Medical Oncology). Mesía Nin R, et al. Clin Transl Oncol. 2010 Nov;12(11):742-8. doi: 10.1007/s12094-010-0589-2. Clin Transl Oncol. 2010. PMID: 20974566
[Patients with clinical criteria for Lynch syndrome with and without mutations in DNA repair genes (MLH1 and MSH2). A challenge for the clinician].
Seijas Tamayo R, Martín Gómez T, Pérez García J, Macías Álvarez L, Sánchez Barba M, Castro Marcos E, Sánchez Tapia EM, González Sarmiento R, Cruz Hernández JJ. Seijas Tamayo R, et al. Med Clin (Barc). 2011 Jul 9;137(4):166-70. doi: 10.1016/j.medcli.2011.03.017. Epub 2011 May 23. Med Clin (Barc). 2011. PMID: 21601892 Spanish.
Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck.
Hitt R, Irigoyen A, Cortes-Funes H, Grau JJ, García-Sáenz JA, Cruz-Hernandez JJ; Spanish Head and Neck Cancer Cooperative Group (TTCC). Hitt R, et al. Ann Oncol. 2012 Apr;23(4):1016-22. doi: 10.1093/annonc/mdr367. Epub 2011 Aug 23. Ann Oncol. 2012. PMID: 21865152 Free article. Clinical Trial.
A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer.
Hitt R, Grau JJ, López-Pousa A, Berrocal A, García-Girón C, Irigoyen A, Sastre J, Martínez-Trufero J, Brandariz Castelo JA, Verger E, Cruz-Hernández JJ; Spanish Head and Neck Cancer Cooperative Group (TTCC). Hitt R, et al. Ann Oncol. 2014 Jan;25(1):216-25. doi: 10.1093/annonc/mdt461. Epub 2013 Nov 19. Ann Oncol. 2014. PMID: 24256848 Free article. Clinical Trial.
Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers.
Zugazagoitia J, Pérez-Segura P, Manzano A, Blanco I, Vega A, Custodio A, Teulé A, Fachal L, Martínez B, González-Sarmiento R, Cruz-Hernández JJ, Chirivella I, Garcés V, Garre P, Romero A, Caldés T, Díaz-Rubio E, de la Hoya M. Zugazagoitia J, et al. Breast Cancer Res Treat. 2014 Nov;148(2):415-21. doi: 10.1007/s10549-014-3167-4. Epub 2014 Oct 24. Breast Cancer Res Treat. 2014. PMID: 25342642
120 results